Background Although non-alcoholic fatty liver disease (NAFLD) is commonly associated
with obesity, it is increasingly being identified in non-obese individuals. We aimed to …

Non‐alcoholic fatty liver disease (NAFLD) has a rapidly rising prevalence worldwide and is
the most common cause of liver disease in developed countries. In this article, we discuss …

Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of liver disease in the
Western world. Furthermore, it is increasing worldwide, paralleling the obesity pandemic …

Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of liver conditions that
are characterized by excess accumulation of fat in the liver. 1 It is closely associated with …

The prevalence of nonalcoholic fatty liver disease (NAFLD) has increased rapidly and is
associated with obesity in epidemiology and pathogenesis. A new study reports that hepatic …

Nonalcoholic fatty liver disease (NAFLD) is a systemic disorder with a complex multifactorial
pathogenesis and heterogenous clinical manifestations. NAFLD, once believed to be an …

Nonalcoholic fatty liver disease (NAFLD) can develop in lean individuals. Despite a better
metabolic profile, the risk of disease progression to hepatic inflammation, fibrosis, and …

Objective As a subgroup of nonalcoholic fatty liver disease (NAFLD), patients with non‐
obese NAFLD may also have an increased risk of adverse hepatic and metabolic outcomes …

Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disorder occurring in
individuals without significant alcohol consumption [1]. It consists of a spectrum of liver …

Nonalcoholic fatty liver disease (NAFLD) affects about a third of the world's adult population
and is a major public health concern. NAFLD is defined by the presence of hepatic steatosis …